Medicinal Chemistry Research

短名Med Chem Res
Journal Impact2.48
国际分区CHEMISTRY, MEDICINAL(Q3)
期刊索引SCI Q3中科院 4 区
ISSN1054-2523, 1554-8120
h-index59
国内分区医学(4区)医学药物化学(4区)

药物化学研究 (MCRE) 发表关于广泛主题的论文,有利于具有重要、新和最新信息的研究。尽管该期刊的同行评审过程要求很高,但 MCRE 仍然以快速发表而自豪,部分原因在于提交的长度。该杂志发表了关于各种主题的重要研究,其中许多强调分子生物学的结构-活性关系。

期刊主页投稿网址
涉及主题化学生物生物化学有机化学医学立体化学遗传学物理组合化学内科学药理学体外核磁共振药物化学基因
出版信息出版商: Birkhauser Boston出版周期: Monthly期刊类型: journal
基本数据创刊年份: 1996原创研究文献占比84.97%自引率:3.80%Gold OA占比: 6.73%
平均审稿周期 网友分享经验:平均5.0个月
平均录用比例网友分享经验:容易

期刊引文格式

这些示例是对学术期刊文章的引用,以及它们应该如何出现在您的参考文献中。

并非所有期刊都按卷和期组织其已发表的文章,因此这些字段是可选的。有些电子期刊不提供页面范围,而是列出文章标识符。在这种情况下,使用文章标识符而不是页面范围是安全的。

只有1位作者的期刊

有2位作者的期刊

有3位作者的期刊

有5位以上作者的期刊

书籍引用格式

以下是创作和编辑的书籍的参考文献的示例。

学位论文引用格式

网页引用格式

这些示例是对网页的引用,以及它们应该如何出现在您的参考文献中。

专利引用格式

最新文章

Quinazolinone-based subchemotypes for targeting HIV-1 capsid protein: design and synthesis

2024-9-14

Medicinal significance of sp2/sp3 hybridized at C-3-substituted indole-containing lead molecules and FDA-approved drugs

2024-9-13

A review on phytochemical constituents, analytical data, and pharmacological properties of the genus Plumeria

2024-9-11

Design, synthesis, anti-tubercular activity, and computational studies of novel 3-(quinolin-3-yl)-1-phenylprop-2-en-1-one derivatives

2024-9-10

Extraction and purification, pharmacological action, synthesis and product development of salidroside: a review

2024-9-8

Translating G-quadruplex ligands from bench to bedside: a Stephen Neidle’s legacy

2024-9-7

Structural insights into G-quadruplex binding by metal complexes: implications for drug design

2024-9-7

A second life for the crystallographic structure of Berenil-dodecanucleotide complex: a computational revisitation thirty years after its publication

2024-9-3

Design, synthesis and evaluation of sesamol-derived acetamides as dual inhibitors of monoamine oxidases and cholinesterases

2024-9-3

A potent therapeutic scaffold fusing quinazolinone/melatonin for future colorectal cancer interventions: design, one-pot synthesis, biological and ADME-tox modeling studies

2024-9-2

Insights into computer-aided G-quadruplex prediction in the digital age

2024-8-28

Design, synthesis and evaluation of imidazo[1,2-a]pyrazin-8(7H)-one derivatives as acetylcholinesterase inhibitors and antioxidants

2024-8-24

Anticancer potential of delphinidin and its derivatives: therapeutic and mechanistic insights

2024-8-14

Terrein: Isolation, synthesis, and upscaling of a functional scaffold for multifaceted biomedical applications

2024-8-10

Dauricine: a review of natural observation, pharmacology, and pharmacokinetics

2024-8-9

Design, synthesis and biological evaluation of potent thiazolidinedione salicylic acid inhibitors against glyoxalase-I as potential anticancer agents

2024-8-9

Exploration of potential antihypertensive peptides derived from farmed Chinese giant salamander (Andrias davidianus)

2024-8-8

Contrasting effect of different crowding agents on pseudoknot RNA stability

2024-8-8

Further exploration of N-4 substituents on the piperazine ring of the hybrid template 5/ 7-{[2-(4-Aryl-piperazin-1-yl)-ethyl]-propyl-amino}-5,6,7,8-tetrahydro-naphthalen-2-ol and its analog: development of an exceptionally potent agonist for D2 & D3 receptors

2024-8-8

Novel monastrol/melatonin hybrids as a new approach for colorectal cancer intervention: design, synthesis, biological activity, and drug-likeness modeling studies

2024-8-8

Novel 2-[(8-hydroxyquinolin-7-yl)(phenyl)methylamino]benzoic acid analogs targeting the active site of botulinum neurotoxins: designing, synthesis, and biological evaluation

2024-8-3

Development of LC-MS/MS methods affording identification and measurement of active metabolites in rat and dog plasma after oral dosing of a penta-ethyl ester prodrug of diethylenetriamine pentaacetic acid

2024-7-30

Structural optimization and biological evaluation of quinoline/naphthalene-based glyoxalase-I inhibitors as anti-cancer candidates

2024-7-30

Targeting selective inhibitors of PARPs in drug discovery and development

2024-7-28

Development of an in vitro model of the neurovascular unit for BBB permeability-linked neuroactivity screening

2024-7-28

A review of trilaciclib, a first-in-class cyclin-dependent kinase 4/6 inhibitor, for the management of metastatic small-cell lung cancer

2024-7-26

Characterization of Allium tuberosum Rottl. peptides with dual inhibitory activities against angiotensin I converting enzyme and dipeptidyl peptidase-IV

2024-7-25

Exploring the decadal evolution of indolizine scaffold for anticancer innovations: a comprehensive analysis

2024-7-25

Synthesis and evaluation of novel biaryl oxazolidinones effective against gram-positive bacterial infections

2024-7-24

Design and discovery of monopolar spindle kinase 1 (MPS1/TTK) inhibitors by computational approaches

2024-7-24

Synthesis and evaluation of 2-methylbenzothiazole derivatives as monoamine oxidase inhibitors

2024-7-24

Nafithromycin (MIQNAF®): ultramodern lactone ketolide designed to treat community acquired bacterial pneumonia (CABP)

2024-7-23

Facile access to novel furoyl-based amide retroisoster inhibitors of LuxR-regulated quorum sensing: conformation analysis and docking studies

2024-7-20

Synthesis, in vitro activity, and molecular docking of caffeic acid and resveratrol derivatives against Alzheimer’s disease-related enzymes

2024-7-19

Ultrasound-assisted synthesis of 4-thiazolidinone Schiff bases and their antioxidant, α-glucosidase, α-amylase inhibition, mode of inhibition and computational studies

2024-7-17

A novel class of indole derivatives: enhanced bioavailability, permeability, and antioxidant efficacy for thromboembolic disease therapy

2024-7-15

Potential therapeutic effects of ester derivatives of Ribavirin against SARS-CoV-2

2024-7-14

ATP-hydrolyzing, DNA-damaging and cytotoxic activities of peptide-targeted cobalt(III) complex with diethylentriamine

2024-7-13

Identification of potential natural product derivatives as CK2 inhibitors based on GA-MLR QSAR modeling, synthesis and biological evaluation

2024-7-10

Bexagliflozin: a comprehensive review of a recently approved SGLT2 inhibitor for the treatment of type 2 diabetes mellitus

2024-7-10

Synthesis and anti-leishmanial activities of uniflorol analogues

2024-7-8

Iron porphyrin-mediated production of carbon monoxide from phenylpyruvic acid: from potential therapeutic and diagnostic use to physiological implications

2024-7-7

Substituted furan-carboxamide and Schiff base derivatives as potential hypolipidemic compounds: evaluation in Triton WR-1339 hyperlipidemic rat model

2024-7-7

Synthesis, structure-activity relationship and evaluation of antifungal activity of tryptanthrin derivatives against drug-resistant Candida albicans

2024-7-4

Ronald T. Borchardt: a pioneer in drug discovery and development

2024-6-28

Peptide-based therapeutics: challenges and solutions

2024-6-27

Redefining the significance of quinoline containing compounds as potent VEGFR-2 inhibitors for cancer therapy

2024-6-27

Targeting cAMP signaling and phosphodiesterase 4 for liver disease treatment

2024-6-26

Design and synthesis of diphenyl-1H-imidazole analogs targeting Mpro/3CLpro enzyme of SARS-CoV-2

2024-6-26

Role of the Caco-2 cell culture model developed in Dr. Ronald T. Borchardt’s lab in modern drug research and development: a perspective from a practitioner

2024-6-25

帮你贴心管理全部的文献

研飞ivySCI,高效的论文管理

投稿经验分享

分享我的经验,帮你走得更远

Built withby Ivy Science
Copyright © 2020-2024
版权所有:南京青藤格致信息科技有限公司